NCT00448604

Completed

Viral Infections in Chronic Obstructive Pulmonary Disease (C...

University Hospital, Geneva Source

Compare

Other study identifiers

Sponsor study identifier

06-257

Study Type

observational

Actual enrollment (reported)

86

Locations

1 country

Sites

1

Timeline

Study Start

May 2007

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

September 2009

Actual (reported)

Study Completion

September 2009

Actual (reported)

Brief Summary

The objectives of the study are

to determine the prevalence of respiratory virus infections in COPD patients, during and outside acute exacerbation
to explore the impact of these viral infections on the outcome of these patients
to explore the association between blood procalcitonin levels and viral infections in this population.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 86 participants
Study completion date: September 2009
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
March 16, 2007
Actual (reported)
First Posted
March 19, 2007
Actual (reported)
Study Start
May 2007
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
September 2009
Actual (reported)
Study Completion
September 2009
Actual (reported)

Last Updated: November 4, 2010
Status Verified: February 2009
Last Update Submitted: November 3, 2010

Conditions

Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Respiratory Tract Infections Virus Diseases

Keywords

procalcitoninacute exacerbationRT-PCRBiological Markers

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients with COPD admitted with acute exacerbation

You may qualify if:

All consecutive patients known or suspected for moderate to very severe COPD and admitted in the emergency center for an acute exacerbation of their COPD

Sponsors & Collaborators

Ligue Pulmonaire Genevoise
Othercollaborator
University Hospital, Geneva
Otherlead

Study Sites (1)

Geneva University Hospital

Geneva, Canton of Geneva, 1211, Switzerland

Related Publications (1)

Kherad O, Kaiser L, Bridevaux PO, Sarasin F, Thomas Y, Janssens JP, Rutschmann OT. Upper-respiratory viral infection, biomarkers, and COPD exacerbations. Chest. 2010 Oct;138(4):896-904. doi: 10.1378/chest.09-2225. Epub 2010 Apr 30.
PMID: 20435659DERIVED

Biospecimen

Retention: SAMPLES WITHOUT DNA

Naso-pharyngeal swaps

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveRespiratory Tract InfectionsVirus DiseasesLung Diseases, Obstructive

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsInfections

Study Officials

Olivier T Rutschmann, MD, MPH
University Hospital, Geneva
PRINCIPAL INVESTIGATOR

Enrollment

86 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER

Study Record Dates

First Submitted

March 16, 2007

First Posted

March 19, 2007

Study Start

May 2007

Date type not reported

This date has not been verified as actual or estimated.

NCT00281203

Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD

Completed

NCT00396604

Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)

Phase 2/3Completed

NCT00106470

Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in Hispanics

Completed

NCT00706602

Predicting the Course of Chronic Obstructive Pulmonary Disease (COPD) in Primary Care

Unknown

NCT00860938

Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD

Phase 4Completed

NCT00533182

Influenza in People With Normal and Weakened Immune Systems

Completed

Age above 18 years

We plan to include 100 patients with a complete work-up and follow-up

Written informed consent will be obtained from every participant

You may not qualify if:

Patients requiring oro-tracheal intubation
Patients unable to give their informed consent due to their clinical condition
Other obvious cause of dyspnea (pulmonary embolism, acute pulmonary edema, lobar pneumonia)
Patients suffering from bronchiectasis, asthma, pulmonary fibrosis and mineral dust pneumoconiosis
Patients with a history of active tuberculosis
Patients with a history of ischemic cerebral stroke and subsequent deglutition dysfunction

Contact the study team to confirm eligibility.

Primary Completion

September 2009

Actual (reported)

Study Completion

September 2009

Actual (reported)

Last Updated

November 4, 2010

Record last verified: 2009-02

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00448604
Data provider: ClinicalTrials.gov
Source updated: 2010-11-04
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:24:41 UTC

Locations

CH(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations